Literature DB >> 8382358

Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta.

S F Ziegler1, T A Bird, J A Schneringer, K A Schooley, P R Baum.   

Abstract

Using a polymerase chain reaction-based approach we have isolated and characterized a cDNA (HPK-6) from human placental RNA encoding a novel receptor protein tyrosine kinase. This receptor tyrosine kinase has a unique extracellular domain, with an immunoglobulin-like domain at the amino terminus followed by three EGF-like cysteine repeats and three fibronectin type III repeats, giving the HPK-6 gene extracellular domain a novel combination of structural motifs. A comparison of the HPK-6 sequence with other receptor tyrosine kinases shows that the HPK-6 gene is the human homolog of the murine tek gene and very closely related to the recently described receptor tyrosine kinase tie. The HPK-6 gene is expressed predominantly in placenta and lung, with a lower level in umbilical vein endothelial cells, brain and kidney. The HPK-6 cDNA, when transfected into COS-7 cells, encodes a 140-kDa protein with in vitro kinase activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382358

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Embryonic angiogenesis: a review.

Authors:  J Wilting; B Christ
Journal:  Naturwissenschaften       Date:  1996-04

Review 2.  Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?

Authors:  J Laurén; Y Gunji; K Alitalo
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 3.  Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling.

Authors:  S Patan
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 4.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

Authors:  Balveen Kaur; Fatima W Khwaja; Eric A Severson; Shannon L Matheny; Daniel J Brat; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

5.  A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption.

Authors:  N Kohmura; T Yagi; Y Tomooka; M Oyanagi; R Kominami; N Takeda; J Chiba; Y Ikawa; S Aizawa
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

Review 6.  Targeting the ANGPT-TIE2 pathway in malignancy.

Authors:  Hanhua Huang; Abhijit Bhat; Gary Woodnutt; Rodney Lappe
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

7.  Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.

Authors:  Ayumi Yoshizaki; Toshiyuki Nakayama; Shinji Naito; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

Review 8.  Transcriptional targeting of tumor endothelial cells for gene therapy.

Authors:  Zhihong Dong; Jacques E Nör
Journal:  Adv Drug Deliv Rev       Date:  2009-04-23       Impact factor: 15.470

9.  Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors.

Authors:  E Hatva; A Kaipainen; P Mentula; J Jääskeläinen; A Paetau; M Haltia; K Alitalo
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 10.  Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance.

Authors:  Elaine Xu; Michael Schwab; André Marette
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.